HUE060711T2 - Makrociklusos vegyületek betegségek kezelésére - Google Patents
Makrociklusos vegyületek betegségek kezeléséreInfo
- Publication number
- HUE060711T2 HUE060711T2 HUE18893293A HUE18893293A HUE060711T2 HU E060711 T2 HUE060711 T2 HU E060711T2 HU E18893293 A HUE18893293 A HU E18893293A HU E18893293 A HUE18893293 A HU E18893293A HU E060711 T2 HUE060711 T2 HU E060711T2
- Authority
- HU
- Hungary
- Prior art keywords
- treating diseases
- macrocyclic compounds
- macrocyclic
- compounds
- diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 150000002678 macrocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762607528P | 2017-12-19 | 2017-12-19 | |
US201862727124P | 2018-09-05 | 2018-09-05 | |
US201862779283P | 2018-12-13 | 2018-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE060711T2 true HUE060711T2 (hu) | 2023-04-28 |
Family
ID=66992951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE18893293A HUE060711T2 (hu) | 2017-12-19 | 2018-12-18 | Makrociklusos vegyületek betegségek kezelésére |
Country Status (26)
Country | Link |
---|---|
US (3) | US10745416B2 (hu) |
EP (2) | EP3728271B1 (hu) |
JP (2) | JP7194188B2 (hu) |
KR (1) | KR20200101358A (hu) |
CN (1) | CN111511746B (hu) |
AU (1) | AU2018392332B2 (hu) |
BR (1) | BR112020012319A2 (hu) |
CA (1) | CA3083674A1 (hu) |
CL (1) | CL2020001632A1 (hu) |
DK (1) | DK3728271T3 (hu) |
EC (1) | ECSP20033467A (hu) |
ES (1) | ES2929467T3 (hu) |
HR (1) | HRP20221502T1 (hu) |
HU (1) | HUE060711T2 (hu) |
IL (1) | IL275265B2 (hu) |
JO (1) | JOP20200152A1 (hu) |
LT (1) | LT3728271T (hu) |
MX (1) | MX2020006490A (hu) |
PH (1) | PH12020550901A1 (hu) |
PL (1) | PL3728271T3 (hu) |
PT (1) | PT3728271T (hu) |
RS (1) | RS63787B1 (hu) |
SG (1) | SG11202005590PA (hu) |
SI (1) | SI3728271T1 (hu) |
TW (1) | TW201930312A (hu) |
WO (1) | WO2019126121A1 (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI787018B (zh) | 2015-11-02 | 2022-12-11 | 美商纜圖藥品公司 | 轉染過程重排之抑制劑 |
KR20200089264A (ko) | 2017-10-18 | 2020-07-24 | 인사이트 코포레이션 | Pi3k-감마 저해제로서의 3차 하이드록시기로 치환된 축합된 이미다졸 유도체 |
RS62710B1 (sr) | 2017-12-19 | 2022-01-31 | Bristol Myers Squibb Co | Triazol n-vezane karbamoil cikloheksil kiseline kao lpa antagonisti |
ES2929467T3 (es) | 2017-12-19 | 2022-11-29 | Turning Point Therapeutics Inc | Compuestos macrocíclicos para tratar enfermedades |
FI3773589T3 (fi) | 2018-04-03 | 2024-02-01 | Blueprint Medicines Corp | Ret-estäjä käytettäväksi ret-muunnoksen sisältävän syövän hoidossa |
CN112703014A (zh) | 2018-08-10 | 2021-04-23 | 缆图药品公司 | Egfr突变型癌症的治疗 |
MX2021004538A (es) | 2018-10-22 | 2021-09-10 | Esker Therapeutics Inc | Inhibidores de tyk2 y sus usos. |
WO2020257165A1 (en) * | 2019-06-19 | 2020-12-24 | Turning Point Therapeutics, Inc. | Macrocycles for use in treating disease |
AU2020294627A1 (en) | 2019-06-19 | 2022-02-17 | Turning Point Therapeutics, Inc. | Polymorphs of a macrocyclic kinase inhibitor |
WO2020257189A1 (en) * | 2019-06-19 | 2020-12-24 | Turning Point Therapeutics, Inc. | Macrocycles for treating disease |
WO2021027503A1 (zh) * | 2019-08-12 | 2021-02-18 | 罗欣药业(上海)有限公司 | 三环类化合物、其制备方法、中间体及应用 |
CN114929710B (zh) * | 2019-12-03 | 2024-03-29 | 特普医药公司 | 用于治疗疾病的巨环 |
JP2023528907A (ja) | 2020-06-04 | 2023-07-06 | シンノハブ ファーマシューティカル カンパニー,リミティド | 大環状構造を有する化合物及びその使用 |
WO2023060022A1 (en) * | 2021-10-05 | 2023-04-13 | Turning Point Therapeutics, Inc. | Synthesis of macrocyclic compounds |
WO2024017380A1 (zh) * | 2022-07-22 | 2024-01-25 | 南京明德新药研发有限公司 | 含三并环的大环类化合物及其应用 |
WO2024040131A1 (en) * | 2022-08-17 | 2024-02-22 | Treeline Biosciences, Inc. | Pyridopyrimidine kras inhibitors |
JP2024120437A (ja) | 2023-02-24 | 2024-09-05 | キヤノン株式会社 | 撮像装置、撮像装置の制御方法、及びプログラム |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0690843B1 (en) * | 1993-03-25 | 2000-08-30 | PHARMACIA & UPJOHN COMPANY | Formyl- or cyano- substituted indole derivatives having dopaminergic activity |
YU49200B (sh) | 1993-12-07 | 2004-09-03 | Eli Lilly And Company | Inhibitori proteinske kinaze c |
RS49779B (sr) | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
AU2737102A (en) | 2000-12-08 | 2002-06-18 | Ortho Mcneil Pharm Inc | Macroheterocylic compounds useful as kinase inhibitors |
US8815872B2 (en) | 2008-09-08 | 2014-08-26 | Merck Patent Gmbh | Macrocyclics pyrimidines as aurora kinase inhibitors |
CN102224153B (zh) | 2008-09-22 | 2014-04-30 | 阵列生物制药公司 | 作为trk激酶抑制剂的取代的咪唑并[1,2-b]哒嗪化合物 |
KR102037619B1 (ko) | 2008-10-22 | 2019-10-28 | 어레이 바이오파마 인크. | TRK 키나아제 억제제로서 치환된 피라졸로[1,5a] 피리미딘 화합물 |
PE20131197A1 (es) | 2008-10-31 | 2013-11-06 | Genentech Inc | Compuestos de pirazolopirimidina como inhibidores de jak y composiciones farmaceuticas que los contienen |
NZ598766A (en) | 2009-10-13 | 2013-09-27 | Elanco Animal Health Ireland | Macrocyclic integrase inhibitors |
SA111320200B1 (ar) | 2010-02-17 | 2014-02-16 | ديبيوفارم اس ايه | مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة |
DK2918588T3 (en) | 2010-05-20 | 2017-08-28 | Array Biopharma Inc | Macrocyclic compounds as TRK kinase inhibitors |
US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
EP2508607A1 (en) | 2011-04-07 | 2012-10-10 | Helmholtz-Zentrum für Infektionsforschung GmbH | Medicament for liver regeneration and for treatment of liver failure |
WO2013001310A1 (en) | 2011-06-30 | 2013-01-03 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Macrocyclic compounds and their use as cdk8 inhibitors |
BR112014003802A2 (pt) | 2011-08-19 | 2017-06-13 | Merck Sharp & Dohme | composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento |
DK2760867T3 (en) | 2011-09-30 | 2016-04-11 | Oncodesign Sa | Macrocyclic FLT3 kinase inhibitors |
DK2822953T5 (en) | 2012-03-06 | 2017-09-11 | Pfizer | Macrocyclic derivatives for the treatment of proliferative diseases |
MX345830B (es) | 2012-03-09 | 2017-02-17 | Lexicon Pharmaceuticals Inc | Compuestos a base de pirazol[1,5-a]pirimidina, composiciones que los comprenden, y metodos para su uso. |
JP6418949B2 (ja) | 2012-03-09 | 2018-11-07 | レクシコン ファーマシューティカルズ インコーポレイテッド | イミダゾ[1,2−b]ピリダジン系化合物、それを含む組成物、及びそれらを使用する方法 |
GB201205669D0 (en) | 2012-03-30 | 2012-05-16 | Agency Science Tech & Res | Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof |
CN110317214B (zh) | 2014-01-24 | 2022-11-22 | 特普医药公司 | 作为蛋白质激酶的调节剂的二芳基巨环 |
US10457691B2 (en) * | 2014-07-21 | 2019-10-29 | Dana-Farber Cancer Institute, Inc. | Macrocyclic kinase inhibitors and uses thereof |
AU2016287568B2 (en) | 2015-07-02 | 2020-08-20 | Turning Point Therapeutics, Inc. | Chiral diaryl macrocycles as modulators of protein kinases |
EP4397665A3 (en) | 2015-07-06 | 2024-08-21 | Turning Point Therapeutics, Inc. | Diaryl macrocycle polymorph |
AU2016296878B2 (en) | 2015-07-21 | 2020-12-17 | Turning Point Therapeutics, Inc. | Chiral diaryl macrocycles and uses thereof |
CN110407856B (zh) * | 2016-03-03 | 2021-04-13 | 深圳市塔吉瑞生物医药有限公司 | 一种大环化合物及包含该化合物的组合物 |
CN106008531B (zh) * | 2016-05-30 | 2019-01-11 | 上海交通大学 | 多环稠合大环内酰胺类化合物的抗胰腺癌用途 |
RU2019105587A (ru) | 2016-07-28 | 2020-08-28 | Тёрнинг Поинт Терапьютикс, Инк. | Макроциклические ингибиторы киназ |
TWI808958B (zh) | 2017-01-25 | 2023-07-21 | 美商特普醫葯公司 | 涉及二芳基巨環化合物之組合療法 |
EP3658148B1 (en) | 2017-07-28 | 2024-07-10 | Turning Point Therapeutics, Inc. | Macrocyclic compounds and uses thereof |
KR20200089264A (ko) | 2017-10-18 | 2020-07-24 | 인사이트 코포레이션 | Pi3k-감마 저해제로서의 3차 하이드록시기로 치환된 축합된 이미다졸 유도체 |
RS62710B1 (sr) | 2017-12-19 | 2022-01-31 | Bristol Myers Squibb Co | Triazol n-vezane karbamoil cikloheksil kiseline kao lpa antagonisti |
ES2929467T3 (es) | 2017-12-19 | 2022-11-29 | Turning Point Therapeutics Inc | Compuestos macrocíclicos para tratar enfermedades |
EP3728270A4 (en) * | 2017-12-19 | 2021-06-23 | Turning Point Therapeutics, Inc. | MACROCYCLIC KINASE INHIBITORS AND THEIR USES |
GB201721235D0 (en) | 2017-12-19 | 2018-01-31 | Syngenta Participations Ag | Polymorphs |
WO2019120267A1 (zh) | 2017-12-22 | 2019-06-27 | 成都先导药物开发股份有限公司 | 一种咪唑并[1,2-b]哒嗪大环类激酶抑制剂 |
KR102621272B1 (ko) | 2018-04-18 | 2024-01-05 | 히트젠 주식회사 | 거대고리 키나아제 억제제 |
-
2018
- 2018-12-18 ES ES18893293T patent/ES2929467T3/es active Active
- 2018-12-18 AU AU2018392332A patent/AU2018392332B2/en active Active
- 2018-12-18 EP EP18893293.3A patent/EP3728271B1/en active Active
- 2018-12-18 JP JP2020533594A patent/JP7194188B2/ja active Active
- 2018-12-18 PT PT188932933T patent/PT3728271T/pt unknown
- 2018-12-18 MX MX2020006490A patent/MX2020006490A/es unknown
- 2018-12-18 SI SI201830779T patent/SI3728271T1/sl unknown
- 2018-12-18 PL PL18893293.3T patent/PL3728271T3/pl unknown
- 2018-12-18 HR HRP20221502TT patent/HRP20221502T1/hr unknown
- 2018-12-18 KR KR1020207017739A patent/KR20200101358A/ko not_active Application Discontinuation
- 2018-12-18 DK DK18893293.3T patent/DK3728271T3/da active
- 2018-12-18 HU HUE18893293A patent/HUE060711T2/hu unknown
- 2018-12-18 CA CA3083674A patent/CA3083674A1/en active Pending
- 2018-12-18 RS RS20221099A patent/RS63787B1/sr unknown
- 2018-12-18 LT LTEPPCT/US2018/066158T patent/LT3728271T/lt unknown
- 2018-12-18 EP EP22191652.1A patent/EP4151641A1/en active Pending
- 2018-12-18 WO PCT/US2018/066158 patent/WO2019126121A1/en unknown
- 2018-12-18 CN CN201880082563.6A patent/CN111511746B/zh active Active
- 2018-12-18 BR BR112020012319-6A patent/BR112020012319A2/pt unknown
- 2018-12-18 SG SG11202005590PA patent/SG11202005590PA/en unknown
- 2018-12-18 JO JOP/2020/0152A patent/JOP20200152A1/ar unknown
- 2018-12-19 TW TW107145927A patent/TW201930312A/zh unknown
-
2020
- 2020-01-30 US US16/777,717 patent/US10745416B2/en active Active
- 2020-05-05 US US16/866,983 patent/US11286265B2/en active Active
- 2020-06-10 IL IL275265A patent/IL275265B2/en unknown
- 2020-06-15 PH PH12020550901A patent/PH12020550901A1/en unknown
- 2020-06-17 CL CL2020001632A patent/CL2020001632A1/es unknown
- 2020-06-19 EC ECSENADI202033467A patent/ECSP20033467A/es unknown
-
2022
- 2022-02-14 US US17/670,665 patent/US20220306652A1/en active Pending
- 2022-12-09 JP JP2022197141A patent/JP2023027237A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI3728271T1 (sl) | Makrociklične spojine za zdravljenje bolezni | |
HK1247202A1 (zh) | 用於治療癌症的化合物 | |
SG11201705093UA (en) | Composition for treating il-6-related diseases | |
IL249229B (en) | Compounds for the treatment of brain cancer | |
GB201709402D0 (en) | Compounds for treating t-pll | |
IL251790A0 (en) | Compounds include thiazole for the treatment of culture diseases | |
IL259297A (en) | Heterocyclic compounds for the treatment of disease | |
ZA201906047B (en) | Compounds for treating tuberculosis | |
GB201716942D0 (en) | Therapeutic compounds | |
ZA201901578B (en) | Combinations including abx196 for the treatment of cancer | |
EP3383852A4 (en) | COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | |
PL3630754T3 (pl) | Związki izoindolinoacetylenowe do leczenia nowotworu | |
EP3261635A4 (en) | Compounds for treating ocular diseases | |
GB201420348D0 (en) | Compounds for treating neurodegenerative diseases | |
ZA201805215B (en) | Preparation for nasal-nasopharyngeal treatment | |
GB201715210D0 (en) | Macrocyclic compounds | |
ZA201704589B (en) | Compounds for the treatment of cancer | |
GB201712395D0 (en) | Therapeutic compounds | |
GB201712392D0 (en) | Therapeutic compounds | |
GB201712388D0 (en) | Therapeutic compounds | |
GB201712393D0 (en) | Therapeutic compounds | |
GB201712394D0 (en) | Therapeutic compounds | |
GB201712390D0 (en) | Therapeutic compounds | |
GB201704125D0 (en) | Macrocyclic Compounds | |
GB201704121D0 (en) | Macrocyclic compounds |